Orthopedic Biomaterials: Merging Biomechanics with Biotechnology
The Link Between Biomaterials and Minimally Invasive Surgery
The increasing demand for minimally invasive surgery (MIS) is a powerful driver in the Orthopedic Biomaterial Market. A key report on the Orthopedic Biomaterial Market highlights this connection. MIS techniques, which use smaller incisions and cause less tissue damage, require specialized implants and instruments. Biomaterials used in MIS must be delivered through narrow cannulas and often need to be expandable or self-curing once in place. This has led to the development of innovative materials like injectable bone cements and resorbable tissue fixation devices that are specifically designed for these procedures. The discussion here centers on how MIS benefits patients with shorter hospital stays, reduced pain, and faster recovery. The continued development of biomaterials that are compatible with MIS is essential for the future of orthopedics, as it represents a shift towards less traumatic, more efficient patient care.